Skip to main content
Clinical Trials/NL-OMON53649
NL-OMON53649
Not yet recruiting
Not Applicable

Safety and feasibility of the use of cryoablation in patients with brain neoplasm - Cryoablation of brain neoplasm

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
brain neoplasm
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
30
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \>18 years
  • 2\. Tumor suspected as glioma (1\. Astrocytoma, IDH mutant 2\. Oligodendroglioma,
  • IDH\-mutant and 1p/19q\-codeleted 3\. Glioblastoma, IDH\-wildtype), meningioma (WHO
  • gr. 1 and gr 2\), or brain metastasis based on preliminary diagnosis for which
  • the patient will undergo surgery
  • 3\. Supratentorial or infratentorial localization
  • 4\. Safe trajectory/trajectories possible for ablation of at least 70% of the
  • tumor, avoiding eloquent structures
  • 5\. Karnofsky performance scale 70 or more
  • 6\. Sufficient knowledge of the Dutch language to understand the study documents

Exclusion Criteria

  • 1\. \<18 years or \>80 years
  • 2\. Tumor diameter bigger than 10 cm
  • 3\. Unsafe trajectory (eloquent structures could be damaged)
  • 4\. Pregnancy
  • 5\. Contra\-indication for general anesthesia

Outcomes

Primary Outcomes

Not specified

Similar Trials